FibroBiologics Rings the Nasdaq Stock Market Opening Bell
FibroBiologics (Nasdaq: FBLG), a biotechnology company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Pete O'Heeron, Chief Executive Officer, rings the Opening Bell.